SB 969 — Maryland
Health Insurance - Lyme Disease and Related Tick-Borne Illnesses - Long-Term Antibiotic Treatment
Requiring certain insurers, nonprofit health service plans, and health maintenance organizations to provide certain coverage for the full length of long-term antibiotic treatment of Lyme disease and related tick-borne illnesses under certain circumstances; and prohibiting certain insurers, nonprofit health service plans, and health maintenance organizations from placing a quantitative limit on or denying coverage for benefits required under the Act.
Latest action: Hearing 3/13 at 1:00 p.m. · Mar 6, 2026
Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.
Committees: Finance (Senate)
Cross-filed with HB 1375 — the companion bill in the other chamber, as the legislature links it. Each bill keeps its own votes and status; they are never combined here.
Updated Mar 17, 2026
Timeline
First Reading Senate Rules
Feb 13, 2026 · Senate
Rereferred to Finance
Mar 4, 2026 · Senate
Hearing 3/13 at 1:00 p.m.
Mar 6, 2026 · Senate
Sponsored by Johnny Mautz
No recorded floor votes yet.
How we know this
Every line above comes from the Maryland General Assembly record via Open States. The motion text is shown as recorded, so a procedural vote (to amend, refer or reconsider) is not read as a vote on the bill itself. The source does not say which text version each vote was on; every version is linked below.
Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 29, 2026. Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.